PB-U6insert-EF1puro Citations (5)

Originally described in: Developmental barcoding of whole mouse via homing CRISPR.
Kalhor R, Kalhor K, Mejia L, Leeper K, Graveline A, Mali P, Church GM Science. 2018 Aug 9. pii: science.aat9804. doi: 10.1126/science.aat9804. PubMed Journal

---

Articles Citing PB-U6insert-EF1puro

Articles
High-Throughput Analysis Reveals Rules for Target RNA Binding and Cleavage by AGO2. Becker WR, Ober-Reynolds B, Jouravleva K, Jolly SM, Zamore PD, Greenleaf WJ. Mol Cell. 2019 Aug 22;75(4):741-755.e11. doi: 10.1016/j.molcel.2019.06.012. Epub 2019 Jul 16. PubMed
Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities. Clarke R, Terry AR, Pennington H, Hasty C, MacDougall MS, Regan M, Merrill BJ. Mol Cell. 2021 Jan 21;81(2):226-238.e5. doi: 10.1016/j.molcel.2020.12.003. Epub 2020 Dec 29. PubMed
Deletion of lncRNA XACT does not change expression dosage of X-linked genes, but affects differentiation potential in hPSCs. Motosugi N, Okada C, Sugiyama A, Kawasaki T, Kimura M, Shiina T, Umezawa A, Akutsu H, Fukuda A. Cell Rep. 2021 Jun 8;35(10):109222. doi: 10.1016/j.celrep.2021.109222. PubMed
Identifying a gene signature of metastatic potential by linking pre-metastatic state to ultimate metastatic fate. Handler JS, Li Z, Dveirin RK, Fang W, Goodarzi H, Fertig EJ, Kalhor R. bioRxiv [Preprint]. 2024 Aug 17:2024.08.14.607813. doi: 10.1101/2024.08.14.607813. PubMed
Systematic evaluation of the impact of promoter proximal short tandem repeats on expression. Zhang X, Zhang L, Wang E, Benton S, Modolo E, Maksimov M, Shleizer-Burko S, Gong Q, Wang C, Lamkin M, Mendenhall E, Gymrek M, Goren A. bioRxiv [Preprint]. 2025 Sep 17:2025.09.14.676153. doi: 10.1101/2025.09.14.676153. PubMed

If you have published an article using this material, please email us at to have your article added to this page.